Nanobiotix Files Routine 6-K Report
Ticker: NBTX · Form: 6-K · Filed: Apr 14, 2025 · CIK: 1760854
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
Nanobiotix filed a 6-K, just a routine check-in, no major news.
AI Summary
Nanobiotix S.A. filed a Form 6-K on April 14, 2025, reporting its status as a foreign private issuer. The company, incorporated in France with its principal executive office in Paris, is required to file annual reports under Form 20-F. This filing does not contain specific financial updates or material events beyond its routine reporting obligations.
Why It Matters
This filing confirms Nanobiotix's ongoing compliance with SEC reporting requirements for foreign private issuers, providing transparency to investors.
Risk Assessment
Risk Level: low — This is a standard, routine filing by a foreign private issuer and does not contain new material information or indicate any immediate risks.
Key Players & Entities
- Nanobiotix S.A. (company) — Registrant
- 001-39777 (company) — SEC File Number
- 20-F (company) — Annual Report Form
- 6-K (company) — Report Form
- April 14, 2025 (date) — Filing Date
FAQ
What type of filing is Nanobiotix S.A. submitting?
Nanobiotix S.A. is submitting a Form 6-K, which is a Report of Foreign Private Issuer.
When was this Form 6-K filed?
The Form 6-K was filed on April 14, 2025.
Does Nanobiotix S.A. file annual reports under Form 20-F or 40-F?
Nanobiotix S.A. files annual reports under cover of Form 20-F.
Where is Nanobiotix S.A.'s principal executive office located?
Nanobiotix S.A.'s principal executive office is located at 60 Rue de Wattignies, 75012 Paris, France.
What is the SEC file number for Nanobiotix S.A.?
The SEC file number for Nanobiotix S.A. is 001-39777.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 14, 2025 regarding Nanobiotix S.A. (NBTX).